Cardioprotection and antihypertensive therapy: The key importance of addressing the associated coronary risk factors (the Framingham experience)

American Journal of Cardiology

Volumn 77, Issue 6, 1996, Pages B6-B11

  Kannel, William B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; ARTERY DISEASE; ATHEROGENESIS; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DYSLIPIDEMIA; GLUCOSE INTOLERANCE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HYPERTENSION; INSULIN RESISTANCE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0030064128     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89232-6     Document Type: Conference Paper

References (19)

1. Stamler J. Epidemiology and treatment of hypertension. In: Carlson RJ, Cunningham R, eds. Future Directions in Health Care: A New Public Policy. Cambridge, MA: Ballinger, 1978.
2. Wilson PWF, Kannel WB. Hypertension, other risk factors and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management, 2nd ed. New York: Raven Press, 1995: 99.
3. Smith WM. Epidemiology of hypertension. Med Clin North Amer 1977;61:467-486.
4. Drizd T, Dannenberg AL, Engle A. Blood pressure levels in persons 18-74 years of age in 1976-80 and trends in blood pressure from 1960-1980 in the United States. Vital and Health Statistics. 1986; 11(234). Department of Health and Human Services Publication (PHS) 86-1684.
5. Burt VL, Wheltan P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the adult US population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
6. Chartbook on Cardiovascular, Lung and Blood Diseases. Morbidity and Mortality. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 1994.
7. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys. 1960-1991. JAMA 1994;272:202-211.
8. Kannel WB. An epidemiological perspective in hypertension problem solving. Cardiology 1994;85(suppl.1):71-77.
9. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled biennial measurements. Framingham Heart Study. 30-year follow-up. Department of Health and Human Services Publication (NIH) 87-2703. Springfield, VA: Department of Commerce, National Technical Information Service, 1987.
10. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. N Engl J Med 1984;311: 1144-1147.
11. Austin MA. Epidemiologic assocations between hypertriglyceridemia and coronary heart disease. Semin Thromb Hemost 1988;14:137-142.
12. Carmelli D, Cardon LR, Fabitz R. Clustering of hypertension, diabetes and obesity in adult mate twins: same genes or same environments? Am J Hum Genet 1994;55:566-573.
13. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993;125:1148-1154.
14. Kannel WB, Cobb J. Left ventricular hypertrophy and mortality - results from the Framingham Study. Cardiology 1992;81:291-298.
15. Levy D, Salomen M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90:1786-1793.
16. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertenison 1994;23:869-877.
17. Weber MA. Hypertension as a risk factor syndrome: therapeutic implications. Am J Med 1993;94(suppl 4A):24S-31S.
18. Kannel WB. Potency of vascular risk factors as the basis for antihypertensive therapy. Eur Heart J 1992;13(suppl G):34-42.
19. Kannel WB. Natural history of cardiovascular risk. In: Braunwald E, Hollenberg NK. Atlas of Heart Disease. Hypertension: Mechanisms and Therapy, vol. 1. Philadelphia: Current Medicine, 1994: 5-2-5-22.